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Background: Celiac disease (CD) is an autoimmune disorder of the small intestine which is triggered by dietary
gluten in genetically predisposed (HLA-DQ2/DQ8 positive) individuals. Only a fraction of HLA-DQ2/DQ8 positive
individuals develop CD indicating that other factors have a role in the disorder. Several studies have addressed
intestinal microbiota aberrancies in pediatric CD, but the results are inconsistent. Previously, we demonstrated that
pediatric CD patients have lower duodenal expression of TLR2 and higher expression of TLR9 as compared to
healthy controls (HC) indicating that microbiota may have a role in CD.
Methods: We used bacterial phylogenetic microarray to comprehensively profile the microbiota in duodenal
biopsies of CD (n = 10) and HC (n = 9) children. The expression of selected mucosa-associated genes was assessed
by qRT-PCR in CD and HC children and in treated CD adults (T-CD, n = 6) on gluten free diet.
Results: The overall composition, diversity and the estimated microbe associated molecular pattern (MAMP)
content of microbiota were comparable between CD and HC, but a sub-population profile comprising eight
genus-like bacterial groups was found to differ significantly between HC and CD. In HC, increased TLR2 expression
was positively correlated with the expression of tight junction protein ZO-1. In CD and T-CD, the expression of
IL-10, IFN-g and CXCR6 were higher as co5mpared to HC.
Conclusions: The results suggest that microbiota and altered expression of mucosal receptors have a role in CD. In
CD subjects, the increased expression of IL-10 and IFN-g may have partly resulted from the increased TLR9
expression and signaling.
Keywords: Celiac disease, Microbiota, Gene expression, Duodenum, Host-microbe cross-talkBackground
Celiac disease (CD) is a common chronic immune-
mediated, inflammatory disorder of the small intestine
induced by intolerance to gluten-containing dietary
products [1,2]. When a CD patient consumes gluten, an
inflammatory cascade occurs in the small intestinal mu-
cosa, eventually resulting in an active disease that is
characterized by villous atrophy, crypt hyperplasia and
increased numbers of lymphocytes in the lamina propria
[1,3]. Untreated CD is manifested by gastrointestinal
symptoms, malabsorption and even malnutrition [1,3]
and also by extra-intestinal symptoms such as dermititis* Correspondence: reetta.satokari@helsinki.fi
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reproduction in any medium, provided the orherpetiformis (skin rash) in some individuals [3]. Both
genetic predisposition and environmental factors are
considered to be involved in the development of CD [4].
Individuals who carry the alleles human leukocyte anti-
gen (HLA)-DQ2 or HLA-DQ8 have an increased risk of
developing the disease, but only less than one tenth of
them eventually get CD, indicating that other genetic
factors and/or environmental factors are also important
in the pathogenesis [5]. Recently, 13 new CD risk loci
were identified, bringing the number of known CD loci
to 40 and giving a refined picture of the genetic risk of
CD [6]. Most of these loci contain candidate genes of
immunological function, but the pathways leading from
genetic predisposition to an affected person are poorly
understood [6,7]. The intestinal microbiota is a majorLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have a role in the CD pathogenesis.
Gut colonization starts immediately after birth, and
considerable microbiota maturation takes place during
the first years of life followed by a gradual microbiota
succession until young adulthood [8-10]. A balanced
commensal microbiota contributes to the physiological
development of the gut and the maturation of the
immune system; thereby, alterations in the intestinal
microbiota could play a role in the onset of different dis-
eases, including CD [3,11]. Increased bacterial diversity
and changes in several bacterial groups in the microbiota
of pediatric CD patients have been reported in several
studies [12-16]. However, other recent studies have
failed to show major microbiota differences between
children with and without CD [17-19]. Two recent stud-
ies have addressed the microbiota in infants with a gen-
etic predisposition to CD [4,11]. Both of these reported
the microbiota of predisposed infants to be different
from that of non-predisposed, but while Sellitto et al.
reported a reduction or lack of Bacteroides in predis-
posed infants [4], De Palma et al. found that Bacteroides
fragilis and staphylococci were increased and bifidobac-
teria were reduced in genetically susceptible infants [11].
Although the idea that the microbiota is involved in the
etiology of CD has been addressed in numerous studies,
the results on specific CD-associated microbiota changes
remain inconclusive.
Recently, we demonstrated that pediatric CD patients
have decreased duodenal expression of Toll-like receptor
2 (TLR2) and the negative regulator of Toll-receptor sig-
naling (Tollip), and increased expression of TLR9 and
interleukin 8 (IL-8), which is a marker of intestinal inflam-
mation [18]. TLRs are a family of pattern recognition re-
ceptors, which recognize conserved microbe-associated
motifs such as lipopolysaccharides (LPS, ligand for TLR4),
lipoproteins and lipoteichoeic acids (LTA, ligand for
TLR2), flagellin (TLR5) and nucleic acid motifs (TLR3, 7
and 9). Intestinal epithelial homeostasis is dependent on
the activation of TLRs at adequate levels in order to keep
defense against microbes balanced and to avoid an exces-
sive inflammatory response to gut commensals [20,21].
Further, TLR signaling is known to affect epithelial barrier
function by having a bearing on the expression of tight
junction proteins, mucus protein mucin 2 and antimicro-
bial peptides such as RegIII-γ [20,21]. Thus, our previous
results suggested that microbiota may play a role in the
etiology of CD, but we were unable to reveal aberrancies
in the duodenal mucosal microbiota of pediatric CD by
targeting selected bacterial groups by quantitative PCR
(qPCR) [18].
The objectives of the present study were to com-
prehensively characterize the total duodenal mucosal
microbiota and to re-evaluate the possible microbiotadifferences in pediatric CD patients and healthy controls
by using a high-throughput bacterial phylogenetic micro-
array (HITChip). Further, the expression of nine mucosa-
associated genes, IL-10, interferon-gamma (IFN-γ), tumor
necrosis factor alpha (TNF-α), a tight junction protein
zonula occludens-1 (ZO-1), a gap junction protein
connexin-43 (Cx43), a mucus protein mucin 2 (MUC2),
an antimicrobial peptide RegIIIγ, a chemokine CXCL16
and its receptor CXCR6 were measured by using a quanti-
tative reverse transcription-PCR (qRT-PCR).
Methods
Study subjects and DNA and RNA extraction
Duodenal biopsy samples were collected from 20 Finnish
children and 6 Finnish adults: 10 children with newly
diagnosed CD (median age 9.5 ± 4.1 y; 3-14 y, 4 males and
6 females) before the implementation of gluten-free diet
(GFD), 10 healthy control (HC) children (median age
8.5 ± 3.8 y; 4-16y, 4 males and 6 females) with gastrointes-
tinal complaints or other reasons for esophagogastroduo-
denoscopy (abdominal pain - 4 patients, gastroesophageal
reflux disease – 2 patients, growth retardation – 2 patients
esophagitis -1 patient, achalasia – 1 patient) and 6 adults
(median age 46 ± 11.4 y; 30-60 y) with CD who had been
on a GFD at least for a year (treated CD, T-CD). All HC
and T-CD subjects had both negative celiac serology and
normal small intestinal mucosa (Marsh 0 lesions), while
CD patients had both positive celiac serology mar-
kers (anti-tissue transglutaminase antibodies and/or anti-
endomysium antibodies) and villous atrophy and crypt
hyperplasia (Marsh III lesions) in duodenal biopsy. The
study subjects were the same as in our previous study [18]
and the same DNA and RNA preparations were used in
this study. The DNA and RNA extraction and purification
protocols were described in detail earlier [18].
Quantitative reverse-transcriptase-PCR (qRT-PCR)
Gene expression assays were performed using compara-
tive Ct (threshold cycle)-method with ABI 7300 Real
Time PCR System. (Applied Biosystems/Life Technolo-
gies Corporation, Carlsbad, CA). Taqman Gene Expres-
sion Assays (Applied Biosystems) used in analyses were:
IL-10, assay ID: Hs00174086_m1; IFN-g, assay ID:
Hs00174143_m1; TNF-α assay ID: Hs00174128; ZO-1,
assay ID: Hs01551861_m1; Cx43, assay ID: Hs00748
445_s1; MUC2, assay ID: Hs03005103_g1; RegIIIγ, assay
ID: Hs01595405_m1; CXCL16, assay ID: Hs0022
2859_m1; CXCR6, assay ID: Hs01890898_s1. Gene ex-
pression assays were performed according to kit’s proto-
col. Reactions were run in three replicates in a total
volume of 20 μl or 50 μl with 25 ng of cDNA in each.
Thermal cycler conditions used were 1) 50°C for 2 min,
2) 95°C for 10 min, 3) 95°C for 15 sec, 4) 60°C for
1 min. Steps 3 and 4 were repeated 40 times. Gene
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control (a house-keeping gene) to normalize the gene
expression. Negative control and Universe Human Ref-
erence RNA (Agilent Technologies, Santa Clara, CA) as
a control RNA were included in every PCR run. Results
were analyzed with RQ-Study program (Applied
Biosystems) to receive Ct values for all samples. The
relative expression of genes was then calculated as de-
scribed in detail previously [18].
Microbiota analysis by phylogenetic microarray
The microbiota was analyzed with the bacterial phylo-
genetic microarray –the HITChip (Human Intestinal
Tract Chip) [22-24]. This microarray consists of over
4 800 oligonucleotide probes targeting the V1 and V6
hypervariable regions of the 16S rRNA gene of 1038 in-
testinal phylotypes [22-24]. It allows a comprehensive
and high-resolution analysis of the microbiota compos-
ition at different taxonomic levels. Genus-like level (L2)
taxa correspond to bacteria having 90% or higher simi-
larity in their 16S rRNA gene, whereas L1 taxa corres-
pond to a phylum-like level [22].
The HITChip measurements were performed as previ-
ously described [22-24]. In brief, amplification of 16S
rRNA gene was carried out from 100-200 ng of DNA
with primer T7 prom-Bact-27 F and Bact-1369R [25],
followed by in vitro transcription, dye labeling, fragmen-
tation, and hybridization, as described earlier [22]. The
arrays were scanned with Agilent DNA Microarray
Scanner G2505C (Agilent, USA) and the intensity values
for each image were extracted from the generated im-
ages using Agilent Extraction Software, version 10.7.3.1.
Normalization and quality control of HITChip array data
were performed with scripts in R statistical software, as
described earlier [22,24,26]. The technical replicates
having a Pearson correlation over 0.94 were selected for
further analysis and the replicates were averaged. The
between sample normalization was carried out with
min-max algorithm [27,28]. Signal intensity threshold
was applied to reduce experimental and possible cross-
hybridization noise, as described previously [22].
Estimation of the microbe associated molecular pattern
(MAMP) content
The relative content of selected MAMPs was estimated
from the HITChip profiles summarizing the abundance
of Gram-positive, Gram–negative or flagellated genus-
like bacterial groups. The abundance of Gram-positive
bacteria is assumed to reflect the load of LTA, i.e. TLR2
ligands, the abundance of Gram-negative bacteria the
load of LPS i.e. TLR4 ligands, and the abundance of flag-
ellated bacteria the load of TLR5 ligands. The general
GC% of the microbiome was estimated based on the
genomic GC-content of representative species from eachof the genus-like group (Additional file 1: Table S1),
weighted by the relative abundance of each of these
groups in the total microbiota. The GC% is taken to reflect
the load of unmethylated CpG motifs, i.e. TLR9 ligands,
as a high GC content of a bacterial genome correlates with
a higher number of CpG motifs in the genome (Kant R,
de Vos WM, Palva A, Satokari R, unpublished results)
[29,30].Statistical analysis
The data analysis was performed in R version 2.15.1 (R
Development CT 2012). The sum of signal intensities
for probes targeting a genus-like group was used as a
quantitative measure of the abundance of the group in a
sample [24]. When computing the signal at higher level
taxa, the probe intensities were divided by the number
of known target phylotypes per probe. The signal inten-
sity above threshold was log10-transformed.
The diversity of the microbial profiles was computed by
Simpson’s reciprocal index of diversity (1/D) and Shannon
indices on probe-level data [31,32]. Principal component
analysis (PCA) and Redundancy analysis (RDA) [33,34]
were computed using R packages ‘stats’ and ‘vegan’. The
significance of separation in RDA was assessed with a per-
mutation test [33] using 50000 permutations.
Bacterial groups that are associated with the health
status were selected with 9-fold cross-validation (CV).
The data was split into 9 subsets (folds) of equal size
with stratification such that both CD and HC samples
were present in all folds. In the CV procedure, eight
subsets were used for training, and one subset in turn
was left out for testing. Within each CV fold, six random
forests were learned to predict the study group using a
set of bacteria, selected by: i) choosing the 2, 4, 6, 8, or
10 bacteria having smallest p-values from two-sample
t-test carried out within the training set, or ii) selecting
the bacterial groups with high mean decrease in gini
score from random forest using all bacteria [35]. The
prediction error of the random forests was then esti-
mated with the test data. The feature selection method
with lowest prediction error rate from cross-validation
(that is, 8 bacteria with smallest p-values) was then ap-
plied for the full data, and its prediction error was esti-
mated with 9-fold cross validation. Significance of the
prediction was tested with permutation test using 10,000
permutations.
Differentially present bacterial groups were analyzed
with Student’s t-test assuming two tailed distribution
[36]. False discovery rate (FDR) correction of p-values
was carried out using Benjamini-Hochberg (BH) correc-
tion [37]. The average relative abundance of each
phylum- or genus-like group was estimated by first cal-
culating the percentage of signal intensity within each
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of signal intensities within CD and HC groups.
For relative gene expression, the normality of the data
was tested by Shapiro-Wilk normality test function. When
normality assumption applied, ANOVA and Tukey Hon-
est Significant Differences post-hoc analysis was carried
out. If the data residuals differed significantly from nor-
mality, Kruskal-Wallis and associated posthoc analysis
were carried out [38]. For all analyses, FDR corrected p-
values below 0.05 were considered significant. The corre-
lations between bacterial groups, gene expressions and
MAMP content were estimated by Spearman coefficient,
followed by FDR correction (BH) of p-value.
Ethical considerations
The study was accepted by the ethical committee of the
Hospital District of Southwest Finland. Written in-
formed consent was obtained from all of the study pa-
tients or their parents. Pediatric T-CD subjects could
not be included as a control group in the study, because
in Finland follow-up biopsies are not taken from chil-
dren if celiac serology turns negative within two years
after the implementation of GFD.
Results
Composition of the duodenal mucosal microbiota
HITChip microbiota profiles were obtained from 10 CD
subjects (4 males and 6 females) and 9 healthy controls
(HC, median age 9 ± 4.1 years, 4 males and 5 females)
(no significant difference in median age, one HC was
not included due to a low reproducibility of HITChip
profile, Additional file 2: Table S2).
At the bacterial phylum-like level, representatives from
13 groups were detected in the duodenal mucosa of the
pediatric subjects (Table 1). The phylum-like level mic-
robiota profiles were found to be individual-specific with
large inter-individual variation (Figure 1). Proteobacteria,
Bacilli and Bacteroidetes were found to be the major
bacterial groups in the duodenal mucosa of both CD
and HC (Figure 2). Proteobacteria and Bacilli constituted
each approximately one third of the community while
Bacteroidetes amounted to around 14% (Figure 2). There
were no significant differences in the abundance of bac-
terial phylum-like groups between CD and HC. Simi-
larly, the bacterial diversity was comparable between the
HC and CD groups (Figure 3).
Altogether 65 genus-like groups were detected in the
duodenal biopsies (Table 1). HC and CD shared the
same predominant genus-like groups, whose average
proportion was above 5% of the total signal. The pre-
dominant groups were Sutterella wadsworthensis et rel.,
Streptococcus mitis et rel., Aquabacterium, Streptococcus
bovis et rel., Streptococcus intermedius et rel., and
Prevotella melaninogenica et rel. (Table 1). Among these,the most abundant bacterial groups in both HC and CD
were Sutterella wadsworthensis et rel. and Streptococcus
mitis et rel., both with an average abundance of 14 to
19% (Table 1). No single genus-like bacterial group
abundance differed significantly between HC and CD
(Table 1).The general MAMP content of the duodenal microbiota
The general MAMP content was estimated based on the
microbiota profiles (Table 1). No significant difference
between the abundance of Gram-positive or Gram-
negative bacteria carrying LTA or LPS respectively was
found, nor in the abundance of potentially flagellated
bacteria between HC and CD. Thus, the ligand load for
TLR2, 4 and 5 seems comparable between HC and CD.
In addition, the average GC% content of the total micro-
biota and the relative abundance of high-GC% bacteria
(genomic GC% > 58%) were comparable between the
groups suggesting a similar load of unmethylated CpG
motifs, which are ligands for the TLR9.Celiac disease associated microbiota profile
In PCA and RDA plots, HC vs. CD subjects did not
cluster separately, showing that the groups do not differ
in terms of the total microbiota profile (Additional file 3:
Figure S1, Additional file 4: Figure S2). Moreover, as
already mentioned above, no single genus-like bacterial
group’s abundance differed significantly between HC and
CD (Table 1).
Further analysis was performed with random forests
using feature selection as preprocessing step, where the
best method was chosen from six candidates using cross-
validation. The aim was to identify a possible health
status-related bacterial sub-population within the total
microbiota. The feature selection method resulting in low-
est cross-validated prediction error was to choose a set of
eight genus-like bacteria having lowest p-values from
t-test (Figure 4). Thus, although no single genus-like
group individually differed significantly between HC and
CD, a random forest learned with a profile of selected
eight genus-like groups predicted the health status with
error rate of 31.6%. This is significantly better than ran-
dom guess, having a median error rate of 53%, and 95%
confidence intervals of [32%, 74%].
As can be seen from Table 1, P. melaninogenica et rel.
has a relative abundance of 5.3% and 6.5% in HC and
CD, respectively and it is among the predominant
genus-like groups contributing to the separation be-
tween HC and CD. Also Haemophilus ssp. and Serratia
ssp. had relatively higher abundance in CD, whereas the
other five bacterial groups were higher in HC, see
Table 1.
Table 1 Composition of the duodenal mucosa-associated microbiota in healthy control (HC) and celiac disease (CD)
children: the relative abundance of HITChip genus-like groups and MAMP content estimation
Relative abundance (%)*
Phylum/Order Genus-like phylogenetic group HC CD Gram+/- Flagella GC%
Actinobacteria Propionibacterium 0.80 ± 0.90 1.43 ± 1.31 G+ N 60
Bifidobacterium 0.52 ± 0.60 0.75 ± 0.98 G+ N 61
Bacilli Streptococcus mitis et rel 13.66 ± 11.64 19.35 ± 12.95 G+ N 40
Streptococcus bovis et rel 9.21 ± 10.79 5.72 ± 3.99 G+ N 37
Streptococcus intermedius et rel 6.38 ± 5.00 7.64 ± 5.12 G+ N 38
Gemella 1.47 ± 2.27 1.77 ± 2.54 G+ N 31
Enterococcus 0.28 ± 0.33 0.19 ± 0.22 G+ Y/N 38
Granulicatella 0.24 ± 0.27 0.23 ± 0.28 G+ N 37
Bacillus 0.17 ± 0.46 0.01 ± 0.01 G+ Y/N 38
Aerococcus 0.16 ± 0.19 0.15 ± 0.19 G+ N 41
Bacteroidetes Prevotella melaninogenica et rel 5.29 ± 4.02 6.51 ± 9.75 G- N 41
Allistipes et rel 2.03 ± 2.81 2.02 ± 3.37 G- N 55
Parabacteroides distasonis et rel 1.76 ± 2.34 1.21 ± 2.23 G- N 45
Bacteroides vulgatus et rel 0.92 ± 1.43 0.47 ± 0.88 G- N 42
Tannerella et rel 0.88 ± 1.38 0.60 ± 1.08 G- N 47
Bacteroides splachnicus et rel 0.79 ± 0.69 1.60 ± 2.73 G- N 43
Prevotella tannerae et rel 0.76 ± 1.10 0.51 ± 0.64 G- N 47
Prevotella oralis et rel 0.32 ± 0.29 0.16 ± 0.19 G- N 45
Bacteroides intestinalis et rel 0.32 ± 0.49 0.20 ± 0.29 G- N 43
Prevotella ruminicola et rel 0.29 ± 0.64 0.11 ± 0.14 G- N 48
Bacteroides plebeius et rel 0.25 ± 0.30 0.44 ± 0.69 G- N 44
Bacteroides stercoris et rel 0.17 ± 0.23 0.06 ± 0.07 G- N 46
Bacteroides ovatus et rel 0.16 ± 0.23 0.08 ± 0.12 G- N 42
Bacteroides fragilis et rel 0.10 ± 0.13 0.15 ± 0.28 G- N 44
Clostridium cl. I Clostridia 0.30 ± 0.78 0.01 ± 0.01 G+ Y/N 26
Clostridium cl. III Clostridium stercorarium et rel 0.14 ± 0.23 0.03 ± 0.08 G+ Y 39
Clostridium cl. IV Clostridium orbiscindens et rel 1.14 ± 1.69 0.19 ± 0.17 G+ Y 57
Sporobacter termitidis et rel 0.56 ± 1.31 0.11 ± 0.18 G+ Y 57
Clostridium leptum et rel 0.50 ± 1.07 0.13 ± 0.14 G+ N 50
Anaerotruncus colihominis et rel 0.15 ± 0.41 4E-03 ± 0.01 G+ N 54
Ruminococcus callidus et rel 0.14 ± 0.29 0.06 ± 0.03 G+ N 43
Eubacterium siraeum et rel 0.14 ± 0.40 2E-03 ± 0.01 G+ Y/N 45
Ruminococcus bromii et rel 0.13 ± 0.40 6E-07 ± 2E-06 G+ N 41
Papillibacter cinnamivorans et rel 0.13 ± 0.28 0.01 ± 0.01 G+ N 56
Clostridium cl. IX Veillonella 2.36 ± 1.78 2.61 ± 3.40 G- N 39
Clostridium cl. XI Clostridium difficile et rel 0.13 ± 0.21 0.06 ± 0.02 G+ Y 29
Clostridium cl. XIVa Clostridium symbiosum et rel 2.79 ± 3.03 3.86 ± 2.51 G+ Y 46
Ruminococcus obeum et rel 1.79 ± 2.28 1.48 ± 0.91 G+ N 42
Bryantella formatexigens et rel 0.90 ± 1.34 0.24 ± 0.11 G+ N 50
Coprococcus eutactus et rel 0.81 ± 1.50 0.21 ± 0.16 G+ N 43
Dorea formicigenerans et rel 0.75 ± 1.07 0.25 ± 0.13 G+ N 41
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Table 1 Composition of the duodenal mucosa-associated microbiota in healthy control (HC) and celiac disease (CD)
children: the relative abundance of HITChip genus-like groups and MAMP content estimation (Continued)
Butyrivibrio crossotus et rel 0.48 ± 1.12 0.08 ± 0.09 G+ Y 38
Eubacterium rectale et rel 0.47 ± 0.76 0.62 ± 0.53 G+ Y/N 41
Ruminococcus gnavus et rel 0.28 ± 0.51 0.09 ± 0.04 G+ N 43
Lachnospira pectinoschiza et rel 0.26 ± 0.33 0.30 ± 0.18 G+ Y 44
Clostridium sphenoides et rel 0.20 ± 0.44 0.09 ± 0.17 G+ Y 42
Outgrouping Clostridium XIVa 0.20 ± 0.27 0.21 ± 0.18 G+ Y 33
Anaerostipes caccae et rel 0.10 ± 0.17 0.07 ± 0.09 G+ N 44
Clostridium cl. XV Eubacterium limosum et rel 0.21 ± 0.61 4E-03 ± 0.01 G+ N 48
Clostridium cl. XVI Solobacterium moorei et rel 0.52 ± 1.02 0.04 ± 0.11 G+ N 38
Proteobacteria Sutterella wadsworthensis et rel 19.16 ± 13.81 18.78 ± 16.24 G- N 62
Aquabacterium 9.61 ± 7.08 9.45 ± 9.20 G- Y 66
Xanthomonadaceae 1.93 ± 2.96 1.90 ± 2.09 G- Y 61
Moraxellaceae 1.19 ± 1.13 1.33 ± 1.06 G- N 42
Vibrio 0.86 ± 0.54 1.35 ± 1.11 G- Y 47
Escherichia coli et rel 0.61 ± 0.65 0.50 ± 0.33 G- Y 51
Enterobacter aerogenes et rel 0.60 ± 0.90 0.58 ± 0.63 G- Y 55
Burkholderia 0.45 ± 0.45 0.56 ± 0.47 G- Y 65
Klebisiella pneumoniae et rel 0.40 ± 0.27 0.74 ± 0.50 G- N 57
Oxalobacter formigenes et rel 0.29 ± 0.29 0.29 ± 0.33 G- N 51
Haemophilus 0.25 ± 0.17 0.46 ± 0.31 G- N 39
Pseudomonas 0.22 ± 0.15 0.40 ± 0.30 G- Y 65
Proteus et rel 0.17 ± 0.27 0.04 ± 0.04 G- Y 38
Serratia 0.10 ± 0.07 0.20 ± 0.15 G- Y 56
Uncult. Mollicutes Uncultured Mollicutes 0.20 ± 0.49 0.03 ± 0.02 G- N 31
Summary Proportion of Gram+ bacteria 46.1 ± 26.6 45.4 ± 25.5
Proportion of Gram- bacteria 52.5 ± 26.7 53.4 ± 25.3
Average GC% content of microbiome 48.6 ± 5.8 48.5 ± 6.4
Proportion of high-GC% bacteria 32.7 ± 23.3 33.3 ± 27.0
Propotion of flagellated bacteria 20.4 ± 8.2 19.9 ± 9.4
*Relative abundance of the total microbiota (mean ± standard deviation). No statistically significant differences in the abundance of individual genus-like bacterial
groups between HC and CD.
cl cluster, uncult uncultured, Gram + Gram positive bacteria, Gram- Gram negative bacteria, high-GC% bacteria genomic GC% content is more than 58%,
Y motile/flagellated, N non-motile/non-flagellated, Y/N motility variable (50% of the group were taken to be flagellated).
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The gene expression levels of ZO-1, CXCL16, CXCR6,
IL-10, IFN-γ, TNF-α, Cx43, MUC2, and RegIIIγ in duo-
denal biopsies were assessed by relative quantitative re-
verse transcription-PCR in the HC and CD children.
Biopsies from six T-CD adults were included for com-
parison, because biopsies from T-CD children were not
available (see ethical considerations above). The expres-
sion of ZO-1, CXCL16, CXCR6 could be assessed only
from 8 HC and 9 CD subjects, because RNA of some of
the samples did not suffice after the other qRT-PCR ana-
lysis (Figures 5 and 6).
The gene expression of ZO-1 was decreased in CD as
compared to T-CD (Figure 5). The expression of CXCR6was higher in CD and T-CD as compared to HC (Figure 6A).
The expressions of IL-10 and IFN-γ were higher, whereas
the ratio of IL-10 to IFN-γ was significantly reduced in
both CD and T-CD as compared to HC (Figure 7). The
gene expressions of TNF-α, Cx43, MUC2, RegIIIγ (Table
A2), and CXCL16 (Figure 6B) were found to be compar-
able between the groups.
When correlating of TLR2 expression [18] with the ex-
pression of proteins related to the physical barrier func-
tion or the production of antimicrobial peptides (Cx43,
ZO-1, MUC2 and RegIIIγ), the ZO-1 expression corre-
lated positively with the TLR2 expression in the HC
group (p = 0.03, rho = 0.88). The expression of Cx43
negatively correlated with the relative abundance of
Figure 1 Composition of the duodenal mucosa-associated
microbiota in healthy control (HC and celiac disease (CD)
children. Relative proportions of bacterial phylum-like groups of the
total microbiota are depicted for each individual (HC1-HC9
and CD1-CD10).
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Bulleidia moorei) et rel. (p = 0.03, rho = -0.82). No other
correlations were found between the relative abundance
of genus-like groups or the estimated MAMP content of
the microbiota and the gene expressions (data not
shown).
Discussion
Human small intestine, especially duodenum, is a dis-
tinctive environment for microbial life because of the ex-
cretion of digestive enzymes and bile, and it harbors a
microbiota that is different from the one in the largeFigure 2 Relative proportion of phylum-like groups in the
duodenal microbiota of celiac disease (CD, white columns) and
healthy control children (HC, grey columns). Mean and standard
error are shown for HC (n = 9) and CD (n = 10) groups.intestine [39]. The HITChip analysis showed that repre-
sentatives of the genus Streptococcus constitute 29% and
32% of the total duodenal microbiota in HC and CD
subjects, respectively, and that the signal obtained for all
Bacilli (phylum-like group) predominantly resulted from
streptococci. This is in line with the previous findings
[39,40]. In addition to Bacilli, Proteobacteria, Bacte-
roidetes and Clostridium cluster XIVa were found to be
the most abundant phylum-like groups in the duode-
num. These bacteria have previously been found to be
dominant groups in the ileum, distal duodenum and
proximal jejunum [17,39,41] and in the duodenum [19].
Interestingly, within Proteobacteria a single most abun-
dant genus-like group was found to be Sutterella
wadsworthensis et rel. both in CD and HC subjects,
which suggests that it belongs to the normal duodenal
microbiota. Similarly, Mukhopadhya et al. detected S.
wadsworthensis with an equally high frequency of 84 to
86% in the colonic biopsies of healthy adults (n = 64) or
ulcerative colitis patients (n = 69), showing that the spe-
cies belongs to the normal microbiota of intestinal mu-
cosa and is unlikely to have a role in IBD [42]. Genus
Aquabacterium belonging to the Proteobacteria also had
a relatively high abundance (~9.5%, prevalence 100% in
both CD and HC) in the duodenum of both groups of
children. Previously, Aquabacterium has been detected
in human colonic mucosal biopsy [43], but to our know-
ledge, this is the first time that Aquabacterium has been
described as an abundant inhabitant of the human small
intestine.
In the PCA and RDA analysis, HC and CD subjects
did not cluster separately. Furthermore, none of the 65
genus-like bacterial groups was found to be significantly
different in abundance between HC and CD. Thus, the
overall duodenal microbiota composition seems compar-
able between HC and CD, which is in line with the re-
sults obtained by Ou et al [17] and Nistal et al [19]
using small intestinal biopsies. Moreover, the bacterial
diversity was also found to be comparable between the
study groups. Previously, bacterial diversity assessed by
PCR-T/DGGE has been observed to be increased in chil-
dren with CD [13,16]. It is noteworthy that PCR-D
/TGGE analysis detects only the most abundant bacteria
and therefore may strongly underestimate microbiota di-
versity in complex communities. Our results from high-
throughput microbiota profiling, like the results by
Nistal et al [19], give a more in depth view of the duo-
denal microbiota regarding the bacterial groups inha-
biting duodenal mucosa and the overall diversity. In
addition, several studies have found differences in spe-
cific bacterial groups between HC and CD [12,14,15,44].
The most consistent findings from these studies were
that children with CD have increased counts of Bacter-
oides and reduced counts of bifidobacteria either in feces
Figure 3 Duodenal microbiota diversity in healthy control (HC, n = 9) and celiac disease (CD, n = 10) children. The dominant/common
species richness and evenness was assessed by Simpson Reciprocal (1/D) and overall species richness and evenness was assessed by Shannon
Indices. Boxplot shows 25th to 75th percentile, with a line at median.
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to differ between CD and HC in this study.
As the overall microbiota profile, diversity or individ-
ual genus-like groups did not show a significant differ-
ence between HC and CD, random forest was used to
explore whether a sub-population bacterial profile could
be associated with the health status. A profile of eightFigure 4 Sub-profile of the duodenal microbiota separating
celiac disease (CD) and healthy control (HC) children. A) Eight
HITChip genus-like level bacterial groups selected with random forest
and cross-validation showing higher abundance in either HC (5
groups) or CD (3 groups). The error rate of random forest is 31.6%,
whereas 95% confidence intervals for random assignment are [32%,
74%]. B) The profile of eight bacterial groups separates healthy control
children (HC) and celiac disease children (CD) in redundancy analysis
(RDA). p-value obtained by permutation test (50000 permutations)
is 0.050.bacterial groups was found to distinguish HC from CD.
The abundance of Prevotella melaninogenica, and the
total abundance of Prevotella spp (Table 1) were found
to be higher in CD, which is in line with the results of
Ou et al. [17] Haemophilus et rel. were also found to be
enriched, although insignificantly as an individual bac-
terial group, in CD children by Nistal et al. [19]. Serratia
spp. was also found to be present in higher abundance
in CD. The phylogenetic microarray targets mainly S.
marcescens, which is considered as an opportunistic
pathogen able to cause invasive infections (sepsis, men-
ingitis, pneumonitis) in neonates [45,46]. These bacteria
may impair the intestinal integrity, but their possible role
in CD remains to be elucidated.
In the distinctive profile detected by random forest, P.
oralis, R. bromii, P. cinnamivorans, Proteus and C. ster-
corarium groups are increased in the HC group. R.
bromii is of particular interest, because it acts as key
species for fiber/resistant starch degradation in the intes-
tine [47] feeding butyrate producing bacteria including
P. cinnamivorans [48]. Butyrate is a major source of en-
ergy to the enterocytes and acts as a regulator of gene
expression, inflammation and differentiation in host cells
[49]. Previously, R. bromii has been detected at increased
level in healthy subjects as compared to Crohn’s disease
patients [50], indicating its potential role for benefiting
the gut mucosal homeostasis.
Finally, it should be taken into account that the highly
individual-specific microbiota-profiles may have a strong
impact on the results within small study groups. More-
over, children in the HC group had healthy duodenal
mucosa, but had gastrointestinal complaints or other
reasons for gastroscopy and the possibility of microbiota
alterations in these children as compared to children de-
void of any symptoms can´t be excluded. Therefore, the
profile comprising eight genus-like bacterial groups,
which showed significant difference between CD and
HC should be verified in future studies.
Figure 5 The relative expression of zonula occludens 1 (ZO-1)
(A) and the scatterplot of ZO-1 and TLR2 expressions (B) in
duodenal biopsies. A) Expression of ZO-1 in duodenal biopsies of
healthy control children (HC, n = 8), celiac disease children (CD, n = 9)
and treated celiac disease adults (T-CD, n = 6). The relative gene
expression of ZO-1 is significantly between CD and T-CD (*p < 0.05).
Boxplot shows 25th to 75th percentile with a line at median and the
whiskers represent interquartile range. Samples, which are outside 1.5
times the interquartile range above the upper quartile (3rd quartile)
and below the lower quartile (1st quartile) are denoted by circles.
B) The scatterplot of relative expression of ZO-1 and TLR2 in
duodenal biopsies of HC. The relationship between ZO-1 and TLR2
expressions is estimated by linear regression, and indicated by
dashed line. The effect of slope is significant (p = 0.02), having
coefficient of determination (R2) of 0.63.
Figure 6 The relative expression of CXCL6 (A) and CXCR16 (B)
in duodenal biopsies of healthy control children (HC, n = 8),
celiac disease children (CD, n = 9) and treated celiac adults
(T-CD, n = 6). Boxplot shows 25th to 75th percentile with a line at
median and the whisker represents interquartile range. Samples,
which are outside 1.5 times the interquartile range above the upper
quartile (3rd quartile) and below the lower quartile (1st quartile) are
denoted by circles. A) The difference in CXCR6 expression between
HC and CD or T-CD is statistically significant (*p < 0.05). B) CXCL16
expression shows no significant differences between the groups.
Cheng et al. BMC Gastroenterology 2013, 13:113 Page 9 of 13
http://www.biomedcentral.com/1471-230X/13/113Similar average proportion of Gram-positive and Gram-
negative bacteria, which are the carriers of LTA and LPS,
respectively, was found in CD and HC. Our previous find-
ings from the same cohort showed that the expression of
TLR2 is higher in HC [18]. As the LTA content is compar-
able between HC and CD, the net signaling through TLR2
is presumably higher in HC. In vitro, TLR2 stimulation of
intestinal epithelial cells (IECs) has been shown to in-
crease Cx43 synthesis, the apical reorganization of ZO-1
and trans-epithelial resistance, which reflects the strengthof tight junctions between IECs and barrier function
[51-53]. Although no significant difference was found in
the expression ZO-1 and Cx43 between HC and CD, the
expression of ZO-1 was significantly lower in CD as com-
pared to T-CD. Moreover, there was a significant positive
correlation between the expressions of ZO-1 and TLR2 in
HC further supporting earlier findings, which demon-
strated more permeable epithelial barrier in CD as com-
pared to HC due to the decreased expression of tight
junction proteins [54]. Negative correlation was found be-
tween the abundance of S. moorei et rel. and the ex-
pression of Cx43. Previously this bacterium has been
associated with oral cavity diseases [55] and its possible
down-regulatory effect of Cx43 may facilitate invasion and
colonization. In CD, however, S. moorei et rel. seems to be
irrelevant as it was found to be as abundantly present in
HC and CD.
Figure 7 The relative expression of interleukin-10 (IL-10) (A), interferon gamma (IFNγ) (B) and IL-10 to IFNγ mRNA ratio (C) in
duodenal biopsies of healthy control children (HC, n = 10), celiac disease children (CD, n = 10) and treated celiac adults (T-CD, n = 6).
Boxplot shows 25th to 75th percentile with a line at median and the whisker represents interquartile range. Samples which are outside
1.5 times the interquartile range above the upper quartile (3rd quartile) and below the lower quartile (1st quartile) are denoted by
circles. A) IL-10 expression is significantly different between HC and CD. B) IFNγ expression is significantly different between HC and CD
or T-CD. C) The ratio of IL-10/IFNγ expression is significantly different between HC and CD or T-CD. The significance between study
groups: *p < 0.05.
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receptor in antigen-presenting cells where it mediates ad-
hesion and phagocytosis of both Gram-positive and
Gram-negative bacteria [56]. In addition, it works as a
chemokine for CXCR6-expressing cells such as natural
killer T cells and T helper 1 (Th1) - polarized CD4 T cells
[57]. Since both microbiota alterations and Th1-polarized
inflammation have been linked to the pathogenesis of ce-
liac disease, we decided to evaluate the expression of both
CXCL16 and its receptor CXCR6 in this study. We found
that the expression of cytokine CXCL16 was found to be
comparable in CD and HC and T-CD, whereas the expres-
sion of its receptor CXCR6 was higher in CD and T-CD
as compared to HC. CXCL16 has dual functions as a
transmembrane adhesion molecule and a soluble chemo-
kine [58]. Both the membrane-bound form of CXCL16
and its receptor CXCR6 have been found to be expressed
not only by dendritic cells/macrophages and T cells re-
spectively, but also by IECs [58-60]. Previously, increased
intestinal CXCL16 expression has been observed in the
colonic biopsies of Crohn´s disease patients due to im-
mune cell infiltration [60]. In this study, an increased ex-
pression of CXCR6 was not only observed in the inflamed
mucosa of CD but also in T-CD without immune cell in-
filtration suggesting an altered expression in epithelialcells. However, increased expression of CXCR6 in mucosa
associated immune cells cannot be excluded when stud-
ying whole biopsies with different cell types. Diegelmann
et al observed that in vitro stimulation of CXCR6 activates
several distinct signaling pathways in IECs and they sug-
gested that the CXCL16-CXCR6 chemokine-receptor sys-
tem contributes to the integrity of epithelium and the
regulation of mucosal innate and adaptive immune sys-
tems [60]. To our knowledge our data report for the first
time an increased duodenal expression of CXCR6 in CD
subjects in whom it may have an important role in the
mucosal immunity.
The average genomic GC content (GC%) of the total
microbiota and the proportion of high-GC% bacteria
was found to be comparable between the HC and CD
groups. High GC content of a bacterial genome corre-
lates with a higher number of potentially immunosti-
mulatory CpG motifs in the genome (Kant R, de Vos
WM, Palva A, Satokari R, unpublished results) [29,30]
and thus, the GC% was taken to reflect the load of TLR9
ligands in the microbiota. Consequently, HC and CD are
likely to harbor similar load of TLR9 ligands. Our previ-
ous results from the same cohort showed that the ex-
pression of TLR9 in duodenum is higher in CD [18].
Thus, the signaling through TLR9 is presumably higher
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of TLR9 ligands and higher expression of TLR9. In
immune cells, TLR9 stimulation is known to trigger
Th1 type immune responses [61-63]. Further, a recent
in vitro study demonstrated that apical TLR9 stimulation
of IECs leads to an increased expression of IFN-γ and
IL-10, but not TNF-α from peripheral blood mono-
nuclear cells (PBMCs) on the basolateral side [64]. In
CD patients, increased mucosal expression of IL-10 and
IFN-γ is well documented and has been associated with
the activity of gliadin-reactive T-cells upon the gluten/
gliadin stimulation either in vivo or in vitro [65-69]. We
found that the expression of IL-10 and IFN-γ in the
duodenal mucosa was increased not only in CD but also
in T-CD with gluten-free diet, suggesting for an add-
itional gluten/gliadin-independent route of stimulation.
Similarly to previous studies [65,68,69], TNF-α expres-
sion was found to be unaffected in CD and T-CD as
compared to HC. The ratio of IL-10 to IFN-γ transcripts
was strongly reduced in both CD and T-CD as com-
pared to HC suggesting that although IL-10 expression
was also increased there is a significant inclination to-
wards a Th1 response both in untreated and treated CD.
Since both CD and T-CD had increased expression of
TLR9 [18], we hypothesize that the increased TLR9 sig-
naling in the small intestine may contribute to the per-
sistent activation of Th1 (IFN-γ) signaling pathway
markers in the small intestine found in CD children des-
pite gluten-free diet treatment [70]. Due to the limita-
tions in studying whole biopsies with different cell types
we cannot conclude which of the proposed signaling
routes i.e. the direct TLR9 stimulation of immune cells
or the stimulation of IECs with subsequent triggering of
immune cells would possibly encompass more into the
observed cytokine profile.
Conclusions
Our results suggest that intestinal microbiota and host-
microbe cross-talk play a role in the CD. While the over-
all microbiota composition in the duodenal mucosa was
comparable between the CD and healthy children, a
sub-population profile comprising eight genus-like bac-
terial groups was found to differ significantly between
the study groups. The sub-population of bacteria has po-
tentially a specific role in e.g. maintaining gut homeosta-
sis in the healthy individuals or in compromising the
epithelial function in CD. Secondly, these and our previ-
ous results from the same cohort [18] suggest that al-
tered expression of mucosal receptors and epithelial
host-microbe cross-talk have a role in CD. We hypo-
thesize that increased TLR9 signaling in the duodenum
may contribute to the Th1 response (increased IFN-γ)
found in the small intestinal mucosa of CD subjects even
after the implementation of GFD.Additional files
Additional file 1: Table S1. Properties of HITChip genus-like groups.
Cell wall type (Gram+/Gram-), presence of flagella and the genomic GC%
were used for the estimation of microbe associated molecular pattern
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Additional file 2: Table S2. The duodenal expression levels of nine
mucosa-associated genes in celiac disease (CD) and healthy control (HC)
children and in treated CD adults (T-CD). Table indicates also from which
subjects reproducible HITChip bacterial microarray profiles were obtained.
Additional file 3: Figure S1. Principal component analysis (PCA) of the
duodenal microbiota profiles from healthy control (HC, n = 9) and celiac
disease (CD, n = 10) children at the HITChip genus-like level. The first two
principal components capture 35% and 21% of variance, respectively.
Additional file 4: Figure S2. Redundancy analysis (RDA) of duodenal
microbiota profiles from healthy control (HC, n = 9) and celiac disease
(n = 10) children at HITChip genus-like level. The separation is not
significant (p = 0.41).
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